Physiomics Share Discussion Threads

[davevt] 09/5/2018 14:12

Instead of clutching onto completely the wrong company? Lol

[davevt] 09/5/2018 13:47

It doesn't sell monitors you clueless fool, it's the world's largest supplier of LCD crystals.

[davevt] 09/5/2018 13:47

It doesn't sell monitors you clueless fool, it's the world's largest supplier of LCD crystals.

[margic] 09/5/2018 13:44

Yes, and this Merck is really JVC... apparently!

[davevt] 09/5/2018 13:44

no it doesn't, you just took that from an old article that said 5 billion ANTICIPATED.

[davevt] 09/5/2018 13:30

And their vt tech isn't exceptional, that's why the ten year patents have expired now, and they do next to no revenues with hardly any customers. They only do modelling for dosage and schedule, for tumors only. Did you hear that, tumors only. All the big boys do modelling to DESIGN drugs, and dosage modelling, for HUNDREDS of diseases. Why would any pharma, let alone Merck Germany, who is mainly an LCD crystal supplier, want to buy up a company that can only model dosage for one of their drugs out of the thousands of drugs on the market?? I take it you're new here!

[davevt] 09/5/2018 13:25

You do realise healthcare is a tiny bit of Merck's revenue, that's why they are looking to sell it.

[davevt] 09/5/2018 13:04

Merck are currently still looking to sell their healthcare division, and have had two complete trial failures of their main cancer drug in lung and stomach cancer trials only a couple of months ago. I think the last thing they would be looking at is buying pyc, of which they are their main customer and without their revenues would be running at more of a loss than they are now. More cost efficient to use their services as and when than own them, use them for 'free', but incur more costs than just using them.

[ethelredtheready] 09/5/2018 12:54

Merck could do an RTO to get a London listing...either way PYC will be up for grabs by a Major, most likely this year. Their VT technology is exceptional. That's why Merck, imo won't want to lose out.......DYOR.......any research and see how PYC is a prime candidate for t/o

[spacedust] 09/5/2018 12:10

We need a major RNS otherwise share price drifting back to 5p. Charts looking bad

[davevt] 09/5/2018 11:25

Let me guess, not only did you think we were dealing with the Multi Billion Merck Pharmaceutical company, which was wrong, now you realise its a German company called Merck KGaA, you thought it was a 'division of' the above Pharmaceutical company. Nope. the two companies have nothing to do with each other. One is the one of the largest pharmaceutical companies in the world, the other is a materials and chemical products supplier for mainly industry and technology, with a small healthcare subsidiary on the side, called Merck Sereno. Thats the one using PYCs services.

[davevt] 09/5/2018 11:16

Margic, no those companies are the same. Do you realise Merck Germany's main business is being the largest supplier or LCD crystals for the TV and monitor market, they have a 60 percent market share. Their next biggest market is pigments for the cosmetics market. Their healthcare revenue is only 1 billion of their total revenue, and they are still looking to sell it. Merck Germany and Merck US are completely INDEPENDANT companies, and are both in litigation over who has rights to the trademark.

[margic] 09/5/2018 10:36

Wow. I suppose carlsberg Cyprus isn't really carlsberg. Maybe mc Donald's Thailand, isn't really mc Donald's, Coca Cola Us isn't really Coca Cola uk, Mercedes Germany isn't really Mercedes Malta? BMW China isn't really BMW holland? Shell Texaco Texas isn't really texaco liverpool? It's all a lie guys!

[davevt] 09/5/2018 10:10

Ah bless, look at Stig/Jack still having his mental breakdown because he wasn't aware what he was actually invested in. I hope you do realise there are two Merck's and we are doing nothing with the us giant. The German Merck we work with is a completely different independent company.

[davevt] 09/5/2018 09:36

Smcl, it's not even quite that. It takes pre existing drugs from pharmas, and models dosage amounts and how often to take them, frequency. It doesn't actually model which is 'best' or how to make it better. It's a bit like a company that makes fuel, using another company to model what is the best amount to flow through an injector in an engine with the right amount of air and timing to get the best efficiency.

[davevt] 09/5/2018 09:30

Hms, that copy and paste from myamay is nothing to do with the Merck we are working with.

[hms_trader] 08/5/2018 22:09

Great post myamay - Merck evaluating medicines, we know who our top client is and we know PYC model the impact of medicines on tumours. Remember it was minimum 500K EUR, with so many drugs being tested by Merck that could very well be a lot bigger!